Medical News

RSS

Research highlights complexity of xylazine and fentanyl combination in overdose cases

Unregulated use of fentanyl and overdose deaths have increased dramatically in recent years, and this trend was made more alarming when authorities found fentanyl laced with the animal tranquilizer xylazine.

16 May 2024

Physical activity can be beneficial for cognitive development of children with ADHD

Attention Deficit Hyperactivity Disorder can impact many common childhood milestones and cognitive processes, such as decision-making, inhibitory control, language development, and goal-setting. Studies by University of Rhode Island kinesiology Assistant Professor Nicole Logan have shown that physical activity can be beneficial for the development of such cognitive processes, particularly in children who may have room to improve in those areas.

16 May 2024

£85 million funding to support the international community in tackling antimicrobial resistance

Funding of £85 million will be announced at a global event to support the international community in tackling the growing threat of antimicrobial resistance.

16 May 2024

Research expands understanding of vaccine-induced immune thrombocytopenia and thrombosis

New research led by Flinders University and international experts is expanding understanding of vaccine-induced immune thrombocytopenia and thrombosis (known as VITT).

16 May 2024

HPV vaccination reduces cervical cancer across all socioeconomic groups in England

The human papillomavirus (HPV) vaccination programme in England has not only been associated with a substantial reduction in cervical disease, but has done so in all socioeconomic groups, finds a study published by The BMJ today.

16 May 2024

Climate change may negatively affect the health of people with brain conditions

Climate change, and its effects on weather patterns and adverse weather events, is likely to negatively affect the health of people with brain conditions, argue a UCL-led team of researchers.

16 May 2024

$Blood pressure medications associated with higher fracture risk among nursing home residents$

Blood pressure medications associated with higher fracture risk among nursing home residents

Records from nearly 30,000 nursing home residents indicate that blood pressure medications more than double the risk of life-threatening bone fractures, according to Rutgers Health research.

16 May 2024

New therapy shows greater weight loss in mice by targeting brain's appetite center

A groundbreaking paper in Nature describes a promising new therapy for obesity that leads to greater weight loss in mice than existing medications.

16 May 2024

New guideline issued for antiseizure medication use in pregnant epilepsy patients

A new guideline has been issued to help neurologists and other clinicians determine the best antiseizure medications for people with epilepsy who may become pregnant.

16 May 2024

Infertility treatment linked to higher postpartum heart disease risk

A study by Rutgers Health experts of more than 31 million hospital records shows that infertility treatment patients were twice as likely as those who conceived naturally to be hospitalized with heart disease in the year after delivery.

16 May 2024

Repurposing human-approved drugs for prion disease treatment

Prions are the abnormal, pathogenic agents that are transmissible and are able to induce abnormal folding of specific normal cellular proteins.

16 May 2024

Unveiling the role of neutrophils in lung cancer progression

Lung cancer remains a leading global health concern, responsible for the highest number of cancer-related deaths worldwide.

16 May 2024

CONVINCE trial reveals the effect of long-term colchicine on recurrent stroke and cardiovascular events

In the international CONVINCE trial, presented today (15 May 2024) at the European Stroke Organisation Conference (ESOC) 2024, anti-inflammatory treatment with long-term colchicine did not reduce rates of recurrent stroke and cardiovascular events in patients with non-cardioembolic stroke in the primary intention-to-treat analysis.

16 May 2024

Mechanistic insights into the role of huc-mscs in treating acute liver failure

Acute liver failure (ALF) is a life-threatening clinical problem with limited treatment options. Administration of human umbilical cord mesenchymal stem cells (hUC-MSCs) may be a promising approach for ALF.

16 May 2024

Unraveling the mystery of Alzheimer's resilience at molecular level

Everyone experiences aging in their own way, and factors such as genetics, lifestyle and environment play a role in this process.

16 May 2024

Sensing a Healthier Future with Sustainable Nanomaterials and Biosensors

In this interview conducted at Pittcon 2024 in San Diego, we spoke to this year's Keynote Speaker Professor Omowunmi (Wunmi) Sadik about how sustainable nanomaterials are transforming human health.

From Pittcon 16 May 2024

Clinical trial suggests hypertension self-management strategies may be effective to control blood pressure

The study findings suggest that self-management strategies for hypertension may effectively reduce blood pressure levels over 24 months without increasing healthcare resource utilization or adverse events as compared to usual care.

16 May 2024

Does discrimination cause harm to the body?

Researchers investigate whether experiencing discrimination is associated with accelerated biological processes of aging.

16 May 2024

Cervical cancer rates drop significantly among vaccinated women

The efficiency of the HPV vaccination program in reducing the prevalence of cervical cancers.

16 May 2024

Closed Loop Medicine and Pharmanovia commence OptiZest study for their first precision medicine combination therapeutic

Closed Loop Medicine Ltd, a leading TechBio company developing combination prescription drug plus software therapy products that deliver personalized dose optimization, and Pharmanovia, a global pharmaceutical company that commercializes novel medicines and revitalizes, extends and expands the lifecycle of established medicines, today announced the initiation of their OptiZest study, ID: NCT06372470, and first patient recruitment.

From Closed Loop Medicine 16 May 2024

Medical News

Research highlights complexity of xylazine and fentanyl combination in overdose cases

Physical activity can be beneficial for cognitive development of children with ADHD

£85 million funding to support the international community in tackling antimicrobial resistance

Research expands understanding of vaccine-induced immune thrombocytopenia and thrombosis

HPV vaccination reduces cervical cancer across all socioeconomic groups in England

Climate change may negatively affect the health of people with brain conditions

Blood pressure medications associated with higher fracture risk among nursing home residents

New therapy shows greater weight loss in mice by targeting brain's appetite center

New guideline issued for antiseizure medication use in pregnant epilepsy patients

Infertility treatment linked to higher postpartum heart disease risk

Repurposing human-approved drugs for prion disease treatment

Unveiling the role of neutrophils in lung cancer progression

CONVINCE trial reveals the effect of long-term colchicine on recurrent stroke and cardiovascular events

Mechanistic insights into the role of huc-mscs in treating acute liver failure

Unraveling the mystery of Alzheimer's resilience at molecular level

Sensing a Healthier Future with Sustainable Nanomaterials and Biosensors

Clinical trial suggests hypertension self-management strategies may be effective to control blood pressure

Does discrimination cause harm to the body?

Cervical cancer rates drop significantly among vaccinated women

Closed Loop Medicine and Pharmanovia commence OptiZest study for their first precision medicine combination therapeutic

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News